Overview

Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis

Status:
RECRUITING
Trial end date:
2029-10-01
Target enrollment:
Participant gender:
Summary
This trial seeks to evaluate a management strategy after the acute treatment duration (≥ 3 months of therapeutic anticoagulation) for patients with cancer and catheter-related upper extremity deep vein thrombosis (DVT).
Phase:
PHASE4
Details
Lead Sponsor:
Ottawa Hospital Research Institute
Treatments:
apixaban